Anixa biosciences inc (ANIX)
Balance Sheet / TTM
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Oct'10
ASSETS
Current assets:
Cash and cash equivalents

2,821

3,491

4,396

3,822

4,152

3,055

2,591

4,172

2,846

3,339

1,833

2,876

1,399

2,488

2,049

2,612

3,980

4,369

5,160

6,080

7,809

3,361

3,651

617

776

898

982

1,273

1,713

339

101

130

463

774

551

1,094

Short-term investments in certificates of deposit

2,870

2,350

2,100

2,750

1,750

2,000

2,750

1,250

2,650

3,500

4,251

2,250

600

750

1,900

2,150

2,150

2,400

2,400

2,400

2,650

2,500

2,550

2,050

2,450

0

0

-

-

500

950

1,549

2,049

2,249

2,998

-

Receivables

22

66

1

796

-

306

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

221

-

-

-

-

-

-

-

0

-

45

400

133

828

0

175

-

-

-

0

-

-

-

-

-

-

Inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

-

Prepaid expenses and other current assets

154

184

129

124

333

175

378

298

278

174

140

64

68

162

56

39

55

126

193

42

66

60

100

134

141

160

47

52

67

82

93

107

97

97

60

140

Total current assets

5,868

6,093

6,627

7,493

6,236

5,538

5,719

5,720

5,775

7,013

6,446

5,191

2,068

3,400

4,005

4,801

6,186

6,895

7,754

8,522

10,571

6,321

6,435

3,630

3,367

1,233

1,029

1,325

1,780

922

1,144

1,788

2,609

3,120

3,644

1,234

Investment in Videocon Industries Limited global depository receipts, at fair value (Note 4)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,150

3,977

3,986

4,197

4,269

6,020

5,730

4,728

-

-

-

5,382

-

-

Patents, net of impairment of $1,001,729 and $582,979, respectively, and accumulated amortization of $2,034,381 and $1,615,632, respectively

-

-

-

41

167

837

1,501

1,583

1,664

1,745

1,827

1,908

1,989

2,071

2,152

2,233

2,315

2,396

2,477

2,559

2,640

2,721

2,802

2,884

2,965

0

-

-

-

-

-

-

-

-

-

-

Investment in Volga-Svet, Ltd., at cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

127

127

127

127

127

127

Property and equipment, net of accumulated depreciation of $110,013 and $95,015, respectively

201

200

215

230

66

72

72

57

50

52

141

149

160

156

163

170

145

43

47

51

58

11

9

8

7

8

9

7

11

10

11

13

14

15

17

14

Operating lease right-of-use asset

93

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

6,163

6,293

6,842

7,765

6,470

6,448

7,293

7,360

7,490

8,812

8,414

7,249

4,218

5,628

6,321

7,205

8,647

9,335

10,279

11,132

13,270

9,055

13,399

10,500

10,327

5,439

5,307

7,354

7,522

5,660

5,886

6,793

8,029

8,645

10,168

10,046

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

926

660

723

-

531

512

1,036

380

436

445

1,401

1,249

1,304

1,261

1,216

1,276

-

-

-

635

-

-

-

-

-

-

Secured debenture (Note 7)

-

-

-

-

-

-

-

-

-

-

2,000

3,000

3,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties and contingent legal fees payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

194

207

213

275

243

265

560

152

482

45

207

-

-

-

0

-

-

-

-

-

-

Current portion of convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

667

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

367

585

567

717

612

582

419

452

416

480

-

-

-

373

-

-

-

-

-

-

-

-

-

-

-

-

516

534

489

-

462

558

449

374

278

355

Accrued expenses

705

895

875

877

714

683

710

888

669

409

-

-

-

95

-

-

-

-

-

-

-

-

-

-

-

-

691

609

582

-

129

139

161

85

75

94

Operating lease liability

53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability, at fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,900

2,750

3,430

540

700

970

1,180

0

-

-

-

-

-

-

Loan payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

5,000

5,000

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, nonrefundable development and license fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,187

1,187

1,187

1,187

1,187

1,187

1,187

1,187

1,433

1,444

1,644

2,574

-

Total current liabilities

1,125

1,481

1,443

1,595

1,327

1,265

1,129

1,340

1,086

889

2,926

3,660

3,723

468

531

706

1,244

593

711

688

1,667

1,809

8,356

10,681

11,547

3,211

3,094

3,301

3,438

1,822

1,780

2,132

2,055

2,105

2,927

450

Operating lease liability non-current

40

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent acquisition obligation

-

-

-

-

-

-

-

-

-

-

0

0

4,313

4,171

4,071

3,939

3,812

3,688

3,570

3,454

3,345

3,236

3,136

3,036

2,936

0

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

-

-

-

-

-

-

-

-

Convertible debentures due January 2015, net of discount of $891,402 (Note 6)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,756

1,627

1,512

548

450

453

407

32

-

-

-

0

-

-

Deferred revenue, nonrefundable license fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

235

482

-

-

Loan payable by CopyTele International Ltd. to former affiliate, secured by Videocon Industries Limited global depository receipts (Note1)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

Total liabilities

1,166

1,481

-

-

-

-

-

-

-

-

2,926

3,660

8,037

4,640

4,603

4,645

5,056

4,281

4,281

4,142

5,012

5,045

13,249

-

-

8,760

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies (Note 9)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

-

0

0

-

-

-

0

0

0

0

0

0

0

0

0

0

0

Equity:
Shareholders’ equity:
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding, Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

14

14

14

14

14

14

350

350

14

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, par value $.01 per share; 48,000,000 shares authorized; 20,841,309 and 20,331,754 shares issued and outstanding, respectively

208

203

201

200

194

189

186

168

166

166

151

116

87

87

87

87

87

87

87

2,189

2,197

87

2,368

2,194

2,105

2,092

2,061

1,998

1,851

1,849

1,841

1,814

1,804

1,761

1,721

1,537

Additional paid-in capital

189,646

186,849

185,326

183,932

180,336

175,415

171,007

165,288

164,281

163,931

159,725

156,066

148,848

152,051

151,734

151,472

-

151,101

150,752

147,705

146,727

-

144,444

140,207

136,214

134,750

133,050

130,571

128,654

127,693

126,267

125,957

125,754

125,127

124,347

120,098

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

151,231

-

-

-

-

148,677

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan receivable from former affiliate(Note 1)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

Accumulated deficit

-184,409

-181,817

-179,729

-177,589

-175,052

-170,170

-164,867

-159,390

-158,012

-156,174

-154,388

-152,593

-152,754

-151,165

-150,117

-149,013

-147,741

-146,148

-144,856

-143,254

-141,017

-144,769

-141,616

-142,027

-138,777

-135,163

-132,236

-129,654

-127,178

-125,083

-123,222

-122,593

-121,716

-120,830

-118,039

-113,452

Accumulated other comprehensive (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-46

-219

-210

-

-1,112

638

348

-653

-779

-517

-104

-

-789

1,412

Total shareholders’ equity

5,444

5,235

5,798

6,543

5,479

5,434

6,326

6,066

6,435

7,922

5,487

3,589

-3,818

987

1,718

2,559

3,591

5,053

5,997

6,990

8,257

4,009

149

-4,845

-5,669

-3,320

-3,237

-1,446

-1,324

-1,194

-893

-338

737

1,058

2,241

4,595

Noncontrolling interest (Note 1)

-447

-422

-399

-373

-336

-251

-162

-45

-31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total equity

4,997

4,812

5,399

6,169

5,143

5,183

6,164

6,020

6,404

7,922

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and equity

6,163

6,293

6,842

7,765

6,470

6,448

7,293

7,360

7,490

8,812

8,414

7,249

4,218

5,628

6,321

7,205

8,647

9,335

10,279

11,132

13,270

9,055

13,399

10,500

10,327

5,439

5,307

7,354

7,522

5,660

5,886

6,793

8,029

8,645

10,168

10,046